Four-stage pipeline from target identification to optimized lead compounds, powered by variational quantum eigensolver circuits.
Identify disease-relevant protein targets using quantum-enhanced binding pocket analysis. Leverages VQE ground-state estimation to compute protein folding energies with chemical accuracy (<1.6 mHa).
Screen candidate molecules against target using quantum molecular simulations. Evaluates binding affinity, ADMET properties, and toxicity in parallel across 6 Heron backends at 12.5ms per molecule.
Design antibody-drug conjugate linkers with quantum-optimized stability. Simulates linker-payload bond energies and cleavage kinetics to maximize therapeutic index while minimizing off-target effects.
Multi-objective optimization of lead compounds using quantum annealing and QAOA. Simultaneously optimizes potency, selectivity, solubility, metabolic stability, and synthetic accessibility scores.
Built for production-grade quantum chemistry with hardware-accelerated simulation.
Integrate quantum molecular screening into your existing workflows with our SDK, API, or Salesforce connector.
Native Python client with async support, auto-retry, and streaming results.
OpenAPI 3.1-compliant endpoints. JSON in, JSON out. Works with any HTTP client.
Direct integration with Salesforce Health Cloud and Life Sciences for clinical pipeline management.
Run your first quantum molecular screening in under 60 seconds. No GPU required -- our 913-qubit backend handles the heavy lifting.